Annual Accounts Receivable
$114.94 M
+$26.14 M+29.43%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual accounts receivable is currently $114.94 million, with the most recent change of +$26.14 million (+29.43%) on 31 December 2023. During the last 3 years, it has risen by +$48.94 million (+74.14%). AMPH annual accounts receivable is now at all-time high.AMPH Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$139.63 M
+$8.22 M+6.26%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly accounts receivable is currently $139.63 million, with the most recent change of +$8.22 million (+6.26%) on 30 September 2024. Over the past year, it has increased by +$20.64 million (+17.35%). AMPH quarterly accounts receivable is now at all-time high.AMPH Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.4% | +17.4% |
| 3 y3 years | +74.1% | +78.8% |
| 5 y5 years | +120.3% | +208.6% |
AMPH Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.1% | at high | +90.8% |
| 5 y | 5 years | at high | +153.3% | at high | +208.6% |
| alltime | all time | at high | +403.0% | at high | +650.8% |
Amphastar Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $139.63 M(+6.3%) |
| June 2024 | - | $131.41 M(-4.9%) |
| Mar 2024 | - | $138.11 M(+20.2%) |
| Dec 2023 | $114.94 M(+29.4%) | $114.94 M(-3.4%) |
| Sept 2023 | - | $118.99 M(+13.6%) |
| June 2023 | - | $104.72 M(+4.1%) |
| Mar 2023 | - | $100.64 M(+13.3%) |
| Dec 2022 | $88.80 M(+12.7%) | $88.80 M(+15.2%) |
| Sept 2022 | - | $77.10 M(-4.6%) |
| June 2022 | - | $80.81 M(+10.4%) |
| Mar 2022 | - | $73.17 M(-7.2%) |
| Dec 2021 | $78.80 M(+19.4%) | $78.80 M(+0.9%) |
| Sept 2021 | - | $78.09 M(+15.0%) |
| June 2021 | - | $67.89 M(-12.9%) |
| Mar 2021 | - | $77.94 M(+18.1%) |
| Dec 2020 | $66.00 M(+45.5%) | $66.00 M(+26.0%) |
| Sept 2020 | - | $52.38 M(+5.1%) |
| June 2020 | - | $49.86 M(-13.7%) |
| Mar 2020 | - | $57.78 M(+27.3%) |
| Dec 2019 | $45.38 M | $45.38 M(+0.3%) |
| Sept 2019 | - | $45.26 M(-7.3%) |
| June 2019 | - | $48.82 M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $54.93 M(+5.3%) |
| Dec 2018 | $52.16 M(+44.9%) | $52.16 M(+19.1%) |
| Sept 2018 | - | $43.82 M(+6.1%) |
| June 2018 | - | $41.28 M(+29.5%) |
| Mar 2018 | - | $31.88 M(-11.4%) |
| Dec 2017 | $36.00 M(+34.4%) | $36.00 M(+49.0%) |
| Sept 2017 | - | $24.15 M(+0.1%) |
| June 2017 | - | $24.12 M(-6.8%) |
| Mar 2017 | - | $25.89 M(-3.3%) |
| Dec 2016 | $26.78 M(-19.4%) | $26.78 M(+0.9%) |
| Sept 2016 | - | $26.55 M(+14.8%) |
| June 2016 | - | $23.13 M(+0.2%) |
| Mar 2016 | - | $23.08 M(-30.5%) |
| Dec 2015 | $33.23 M(+45.4%) | $33.23 M(+32.9%) |
| Sept 2015 | - | $25.00 M(+26.0%) |
| June 2015 | - | $19.83 M(-8.4%) |
| Mar 2015 | - | $21.65 M(-5.2%) |
| Dec 2014 | $22.85 M(-7.0%) | $22.85 M(-14.1%) |
| Sept 2014 | - | $26.60 M(+43.0%) |
| June 2014 | - | $18.60 M(-2.7%) |
| Mar 2014 | - | $19.11 M(-22.3%) |
| Dec 2013 | $24.59 M(-32.5%) | $24.59 M |
| Dec 2012 | $36.41 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual accounts receivable year-on-year change?
- What is Amphastar Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Amphastar Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AMPH is $114.94 M
What is the all time high annual accounts receivable for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual accounts receivable is $114.94 M
What is Amphastar Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AMPH annual accounts receivable has changed by +$26.14 M (+29.43%)
What is Amphastar Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AMPH is $139.63 M
What is the all time high quarterly accounts receivable for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly accounts receivable is $139.63 M
What is Amphastar Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AMPH quarterly accounts receivable has changed by +$20.64 M (+17.35%)